FRANKFURT, Feb 10 (Reuters) – Astrazeneca (AZN.L) said global interest in government purchase agreements for its COVID-19 vaccine was driven by strong demand in Latin America, the Middle East and Asia, even as aggregate global demand this year will fall.…

This data comes from the ChinaPulse.com media intelligence and smart news insights monitoring platform.